up home page bottom

French German version Spanish version Italian version

header image

Lancet Study Indicates Cervarix HPV Vaccine Effective Against The Five Most Common Cervical Cancer-Causing Viruses

A study, published in Tuesday’s issue of The Lancet, said that as well as protecting against the two most common virus types, the GlaxoSmithKline Plc’s Cervarix vaccine also provides protection against the next three most common cancer-causing virus types. GlaxoSmithKline Plc’s is Europe’s biggest drug company.